Drug profile · INN
BAL
dimercaprol (BAL) is a heavy metals chelating agent. Route of administration: injection. Current US regulatory status: approved.
dimercaprol (BAL) is a heavy metals chelating agent. Route of administration: injection. Current US regulatory status: approved.
Heavy metals chelating agent
Primary target: Heavy metals
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
🔒 Digital Money report summary: monetary architecture, CBDC, stablecoins and regulation
Digital money is fundamentally an institutional and policy issue, not merely a technical one. The critical questions concern who creates mon…
🔒 WHO Revised Biosimilar Guidelines: Streamlined Regulation for Improved Global Access
WHO's 2022 revised guidelines eliminate the need for mandatory clinical efficacy studies for biosimilars when strong analytical and pharmaco…
Comparative Analysis of FDA and EMA Drug Approval Processes
The FDA employs a centralized and flexible approval system with expedited pathways, potentially leading to shorter review timelines.
dimercaprol (BAL) is a heavy metals chelating agent. Route of administration: injection. Current US regulatory status: approved.
BAL is a marketed brand name for dimercaprol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
dimercaprol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.